Notably, the MUC4/MUC16/MUC20high group in colon cancer (HR = 2.26 [1.51–3.4]) showed a median survival of 1741 days whereas the low risk group did not reach the 50% survival. The gene discussed is MUC16; the disease is colonic neoplasm.